However, our study demonstrates that a different disease entity (diabetes) leads to reduced neutrophil clearance resulting from a moderately reduced ROS production [17] instead of a complete absence of NADPH oxidase activity. This evidence concerns the gene FMO5 and diabetes mellitus.